科研之友
微信
新浪微博
Facebook
分享链接
摘要
Patients treated with atorvastatin calcium 80 mg had a significant 55% reduction in levels of high-sensitivity C-reactive protein (hs-CRP), while those taking atorvastatin 10 mg had a significant 21% reduction in hs-CRP levels at the end of 26 weeks compared to baseline. This is according to the results from the primary endpoint of a new study, the Comparative Atorvastatin Pleiotropic effects (CAP) study.
- 出版日期2009-4
